Shopping Cart
- Remove All
![TargetMol](https://www.targetmol.com/storage/error/oops.webp)
Your shopping cart is currently empty
Description | KRFK TFA, a TSP-1-derived peptide, activates TGF-β and enhances its associated signaling pathways independently of thrombospondin (TSP) receptors like CD47 and CD36. This compound has potential applications in research on chronic ocular surface inflammatory disorders [1]. |
In vitro | KRFK TFA (50 μM; 24 h) activates TGF-β secretion and reduces the expression of dendritic cell maturation markers in TSP-1-deficient bone marrow-derived dendritic cells (BMDCs) [1]. |
In vivo | KRFK TFA (administered as a single dose of 5 μg/5 µL to one eye) significantly prevented the development of chronic ocular surface inflammation in TSP-1 -/- mice [1]. |
Formula | C27H47N9O5.xC2HF3O2 |
Cas No. |
Storage | keep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.